Medicare Enrolled
Dr. Michael Trimba, MD
Interventional Pain Medicine Physician · Brooklyn, NY
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Trimba from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Trimba?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Trimba
Dr. Michael Trimba is an interventional pain medicine physician in Brooklyn, NY, with 20 years of NPI registration. Based on federal Medicare data, Dr. Trimba performed 7,454 Medicare services across 2,248 unique beneficiaries.
Between the years covered by Open Payments, Dr. Trimba received a total of $5,673 from 37 pharmaceutical and/or device companies across 248 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in interventional pain medicine physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Trimba is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 18% volume in NY
$5,673 industry payments
Medicare Practice Summary
Medicare Utilization ↗7,454
Medicare services
Top 18% in NY for interventional pain medicine physician
2,248
Unique beneficiaries
$55
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~373 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Extended-release steroid injection (Zilretta) An injection of triamcinolone acetonide using a preservative-free, extended-release microsphere formulation. The dosage is measured in milligrams. |
2,402 | $13 | $64 |
| Betamethasone steroid injection An injection containing a combination of betamethasone acetate and betamethasone sodium phosphate. |
1,559 | $5 | $50 |
| Ultrasound-guided large joint aspiration or injection This procedure uses ultrasound imaging to guide the removal of fluid from or the injection of medication into a large joint. |
645 | $106 | $191 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
644 | $80 | $150 |
| Viscosupplementation injection for joint An injection of hyaluronic acid or a derivative into a joint to provide lubrication and cushioning. |
470 | $59 | $252 |
| Electromyography of arm or leg muscles A test that measures the electrical activity in the muscles of the arm or leg using a needle electrode. It helps evaluate the health of muscles and the nerve cells that control them. |
249 | $91 | $225 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
196 | $95 | $250 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
182 | $0 | $4 |
| Injection into lower spine canal with imaging guidance A procedure where a substance is injected into the lower part of the spinal canal. The injection is performed using imaging guidance to ensure accurate placement. |
176 | $239 | $750 |
| Telephone medical discussion, 5-10 minutes A phone conversation with a physician lasting between 5 and 10 minutes to discuss medical matters. |
130 | $29 | $100 |
| Nerve conduction studies, 7-8 tests A series of 7 to 8 nerve conduction tests to evaluate how well nerves are sending signals to muscles. |
121 | $161 | $275 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
87 | $45 | $100 |
| Sacral spine nerve root injection with imaging guidance An injection of anesthetic and/or steroid medication into a sacral spine nerve root. The procedure uses imaging guidance to ensure accurate placement. |
73 | $241 | $368 |
| Spine facet joint injection with imaging guidance, single level An injection is administered into a single facet joint of the lower or sacral spine while using imaging guidance to ensure accurate placement. |
72 | $224 | $431 |
| Facet joint injection, second level, with imaging guidance An injection into a lower or sacral spine facet joint using imaging guidance for the second level treated. |
72 | $117 | $560 |
| Injection of anesthetic or steroid into sacroiliac joint with imaging guidance This procedure involves injecting an anesthetic or steroid medication into the joint connecting the lower spine and hip bone. Imaging guidance is used to ensure accurate placement of the injection. |
63 | $161 | $433 |
| Ultrasound guidance for needle placement Use of ultrasound imaging to guide the precise placement of a needle during a medical procedure. |
42 | $53 | $175 |
| Hyaluronan injection (Euflexxa) for joint An injection of hyaluronan or its derivative, specifically Euflexxa, administered directly into a joint space. |
37 | $97 | $251 |
| Facet joint nerve destruction, single joint A procedure to destroy nerves in a single lower or sacral spinal facet joint using imaging guidance to target pain signals. |
30 | $449 | $580 |
| Facet joint nerve destruction, additional joint This procedure uses imaging guidance to destroy nerves in an additional lower or sacral spinal facet joint. |
30 | $336 | $598 |
| Monthly chronic pain management bundle A monthly service for chronic pain management that includes diagnosis, assessment, monitoring, and the development or revision of a person-centered care plan. |
26 | $73 | $93 |
| Injection of carpal tunnel | 25 | $89 | $280 |
| Additional sacral spine nerve root injection with imaging An injection of anesthetic and/or steroid medication into an additional sacral spine nerve root level, guided by imaging. |
24 | $106 | $250 |
| Hyaluronan gel injection for joint An injection of hyaluronan gel into a joint to supplement joint fluid. This procedure is administered as a single dose. |
23 | $404 | $825 |
| Spinal scar tissue removal, multiple sessions A procedure to remove scar tissue within the spinal canal, performed in multiple sessions during a single day. |
16 | $413 | $560 |
| Spine facet joint injection with imaging guidance, single level An injection is administered into a single facet joint of the upper or middle spine while using imaging guidance to ensure accurate placement. |
16 | $249 | $656 |
| Facet joint injection, second level, with imaging An injection into a second spinal facet joint in the upper or middle spine, guided by imaging to ensure accurate placement. |
16 | $126 | $525 |
| Tendon or ligament injection A procedure involving the injection of medication into a tendon or ligament. |
14 | $52 | $350 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
14 | $144 | $300 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$5,673
Total received (2018-2024)
Avg $810/year across 7 years
Top 37% in NY for interventional pain medicine physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
37
Companies
248
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$5,652 (99.6%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$21 (0.4%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$154
2023
$711
2022
$300
2021
$615
2020
$421
2019
$844
2018
$2,629
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
SANOFI-AVENTIS U.S. LLC
$68
Fidia Pharma USA Inc.
$61
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$25
Top 3 companies account for 100.0% of 2024 payments
All-time payments by company (2018-2024) ›
Bioventus LLC
$1,338
SANOFI-AVENTIS U.S. LLC
$424
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$351
Flexion Therapeutics, Inc.
$309
ARBOR PHARMACEUTICALS, INC.
$273
Horizon Therapeutics plc
$272
Fidia Pharma USA Inc.
$256
Kowa Pharmaceuticals America, Inc.
$199
Daiichi Sankyo Inc.
$193
Scilex Pharmaceuticals Inc.
$182
Ferring Pharmaceuticals Inc.
$181
AstraZeneca Pharmaceuticals LP
$164
Sentynl Therapeutics, Inc.
$136
SCILEX PHARMACEUTICALS INC.
$132
Collegium Pharmaceutical, Inc.
$113
Arbor Pharmaceuticals, Inc.
$106
NATUS MEDICAL INCORPORATED
$104
Zimmer Biomet Holdings, Inc.
$99
DePuy Synthes Sales Inc.
$95
ASSERTIO THERAPEUTICS, Inc.
$89
Assertio Therapeutics, Inc.
$87
PFIZER INC.
$84
Pacira Therapeutics, Inc.
$81
Pernix Therapeutics Holdings, Inc.
$77
FIDIA PHARMA USA INC.
$50
Egalet US Inc
$40
Horizon Pharma plc
$33
Pacira Pharmaceuticals Incorporated
$32
Medline Industries, Inc.
$26
RedHill Biopharma Inc.
$25
Hikma Pharmaceuticals USA
$21
Shionogi Inc
$20
Azurity Pharmaceuticals, Inc.
$19
Vertical Pharmaceuticals, LLC
$19
AbbVie Inc.
$17
Allergan, Inc.
$14
Purdue Pharma L.P.
$11
Top 3 companies account for 37.2% of all-time payments
Associated products mentioned in payments ›
Cambia · DUEXIS · Durolane · EUFLEXXA · Edarbi · Edarbyclor · GELSYN-3 · Gel One · Gel-One Cross-linked Hyaluronate · Gralise · HYALGAN · HYM/HYN · HYMOVIS · Horizant · Hymovis · Iovera · Kloxxado · LORZONE · LUCEMYRA · LYRICA · Levorphanol · Levorphanol Tartrate · MOVANTIK · Morphabond ER · Movantik · ORTHOVISC · PENNSAID · RAYOS · RELISTOR · RELISTOR ORAL · REYVOW · SEGLENTIS · SPRIX · SYMPROIC · SYNVISC-ONE · Seglentis · Supartz Fx Sodium Hyaluronate · Symproic · TRILURON · UBRELVY · VIMOVO · VISCO-3 · XTAMPZA · Xtampza ER · ZOHYDRO ER · ZTLido · ZTLido 30 POUCH in 1 CARTON 1 PATCH in 1 POUCH · Zilretta · Zipsor
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Interventional pain medicine physicians within 10 mi
85
Per 100K population
3.2
County median income
$78,548
Nearest hospital
NEW YORK COMMUNITY HOSPITAL OF BROOKLYN, INC.
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Trimba is a mixed practice specialist, with above-average Medicare volume (top 18% in NY), with low-engagement industry engagement, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Trimba experienced with extended-release steroid injection (zilretta)?
Based on Medicare claims data, Dr. Trimba performed 2,402 extended-release steroid injection (zilretta) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Trimba receive payments from pharmaceutical companies?
Yes. Dr. Trimba received a total of $5,673 from 37 companies across 248 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Trimba's costs compare to other interventional pain medicine physicians in Brooklyn?
Dr. Trimba's average Medicare payment per service is $55. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Trimba) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Interventional Pain Medicine Physicians in Brooklyn
Browse interventional pain medicine physicians in Brooklyn ranked by procedure volume and transparency data.
Highest volume
Top Interventional Pain Medicine Physicians in NY
Interventional pain medicine physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Interventional Pain Medicine Physicians in NY
Which NY interventional pain medicine physicians receive the most from drug and device companies.
By company
Bioventus LLC Payments to Doctors
See all physicians who received payments from Bioventus LLC.
By company
SANOFI-AVENTIS U.S. LLC Payments to Doctors
See all physicians who received payments from SANOFI-AVENTIS U.S. LLC.
By company
Salix Pharmaceuticals, a division of Bausch Health US, LLC Payments to Doctors
See all physicians who received payments from Salix Pharmaceuticals, a division of Bausch Health US, LLC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology